What diagnostic work‑up is indicated for a 73‑year‑old man with diabetes mellitus, hyperglycemia, dyslipidemia, stage‑3 chronic kidney disease (estimated glomerular filtration rate ≈56 mL/min), markedly elevated gamma‑glutamyl transferase, vitamin D deficiency, eosinophilia, foul‑smelling dark stools, abdominal distension, insomnia, anxiety, hypertension, and acute severe lumbar pain?

Diagnostic Work-Up for This Complex Presentation

This patient requires urgent imaging of the lumbar spine to evaluate acute severe lumbar pain, stool studies to investigate foul-smelling dark stools, and comprehensive laboratory testing to assess the known CKD, eosinophilia, and metabolic derangements.

Immediate Priority: Acute Lumbar Pain Evaluation

• Lumbar spine imaging (MRI preferred, CT if MRI unavailable) is essential to rule out vertebral compression fracture, spinal stenosis, or malignancy given the acute severe presentation in a 73-year-old with multiple comorbidities
• Consider urgent evaluation for cauda equina syndrome if any bowel/bladder dysfunction accompanies the pain

Gastrointestinal Work-Up for Foul-Smelling Dark Stools

• Fecal occult blood testing to differentiate melena from other causes of dark stools
• Complete blood count to assess for anemia from potential GI bleeding
• Stool studies including ova and parasites given the eosinophilia, which may suggest parasitic infection
• Consider upper endoscopy if melena is confirmed, as this could represent upper GI bleeding
• Fecal elastase and fat quantification if malabsorption is suspected (steatorrhea can cause foul-smelling stools)

CKD Evaluation and Monitoring

For this patient with known stage-3 CKD (eGFR ≈56 mL/min), comprehensive kidney disease assessment is indicated 1:

• Urine albumin-to-creatinine ratio (ACR) to assess for albuminuria, which is critical for CKD staging and prognosis 1
• Repeat serum creatinine with eGFR calculation to confirm chronicity and assess trajectory 1
• Serum cystatin C should be obtained to improve GFR estimation accuracy, particularly given the patient's age and multiple comorbidities 1, 2
• Urinalysis with microscopy to evaluate for hematuria, casts, or other markers of kidney damage 1
• Review of past GFR measurements to establish chronicity (≥3 months of abnormality) and rate of decline 1

Eosinophilia Investigation

• Peripheral blood smear to characterize eosinophil morphology
• Stool ova and parasites (×3 specimens) as parasitic infections are a common cause of eosinophilia
• Serum IgE levels to assess for allergic or parasitic etiologies
• Consider strongyloides serology given potential for hyperinfection in immunocompromised states
• Chest X-ray to evaluate for pulmonary infiltrates (eosinophilic pneumonia, Löffler syndrome)

Metabolic and Hepatobiliary Assessment

Given markedly elevated GGT, comprehensive hepatobiliary evaluation is needed:

• Complete hepatic panel including AST, ALT, alkaline phosphatase, total and direct bilirubin
• Right upper quadrant ultrasound to evaluate for biliary obstruction, hepatic steatosis, or masses
• Lipid panel to assess dyslipidemia severity 3
• Hemoglobin A1c to evaluate diabetes control 1
• Serum 25-hydroxyvitamin D level to quantify deficiency severity 4

CKD-Related Complications Screening

Patients with CKD require monitoring for specific complications 4:

• Serum potassium to assess for hyperkalemia
• Serum bicarbonate to evaluate for metabolic acidosis
• Serum phosphate and calcium to screen for mineral bone disorder
• Parathyroid hormone (PTH) to assess for secondary hyperparathyroidism
• Complete blood count to evaluate for anemia of CKD
• Iron studies (ferritin, transferrin saturation) if anemia is present

Cardiovascular Risk Assessment

Given diabetes, CKD, hypertension, and dyslipidemia, cardiovascular risk stratification is critical 1:

• Electrocardiogram to assess for ischemic changes or arrhythmias
• Lipid panel if not recently obtained
• Blood pressure monitoring to ensure adequate control

Establishing CKD Cause

The cause of CKD should be established using clinical context, history, and targeted testing 1:

• Diabetic nephropathy is likely given diabetes and CKD, but confirmation requires persistent albuminuria 5
• Hypertensive nephrosclerosis is another probable contributor
• Kidney ultrasound to assess kidney size, cortical thickness, and rule out obstruction 1
• Consider kidney biopsy if the clinical picture is atypical or if additional glomerular disease is suspected 1

Common Pitfalls to Avoid

• Do not assume CKD chronicity from a single abnormal eGFR—this could represent acute kidney injury or acute kidney disease requiring repeat testing 1
• Do not overlook the combination of eosinophilia with GI symptoms—parasitic infection must be excluded
• Do not delay lumbar spine imaging in a 73-year-old with acute severe pain, as serious pathology (fracture, malignancy, infection) is more likely in this age group
• Do not use creatinine-based eGFR alone in elderly patients or those with extremes of muscle mass—cystatin C improves accuracy 1, 2